Isolation of the Anticoagulant and Procoagulant Fractions of the Venom of Iranian Endemic Echis carinatus.

IF 1.8 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Nafiseh Nasri Nasrabadi, Nasser Mohammadpour Dounighi, Minoo Ahmadinejad, Hadi Rabiei, Maryam Tabarzad, Mojtaba Najafi, Hossein Vatanpour
{"title":"Isolation of the Anticoagulant and Procoagulant Fractions of the Venom of Iranian Endemic <i>Echis carinatus</i>.","authors":"Nafiseh Nasri Nasrabadi,&nbsp;Nasser Mohammadpour Dounighi,&nbsp;Minoo Ahmadinejad,&nbsp;Hadi Rabiei,&nbsp;Maryam Tabarzad,&nbsp;Mojtaba Najafi,&nbsp;Hossein Vatanpour","doi":"10.5812/ijpr-127240","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The venom of <i>Echis carinatus</i> contains both procoagulant and anticoagulant components that can either promote or block the blood coagulation cascade, and some of these components affect platelet function in different ways.</p><p><strong>Objectives: </strong>The present study focuses on setting up a procedure for the purification of crude venom and designing appropriate clotting tests in order to characterize the procoagulant and anticoagulant fractions of <i>E. carinatus</i> venom.</p><p><strong>Methods: </strong>Chromatographic methods, including gel filtration, ion-exchange chromatography, and reverse-phase high-performance liquid chromatography (HPLC), were applied for purifying these fractions. Coagulant activity testing, prothrombin time (PT), and activated partial thromboplastin time (APTT) were used to determine procoagulant and anticoagulant properties. For measuring molecular weight, 15% SDS-PAGE electrophoresis with a molecular weight standard ranging from 6.5 to 200 kDa was used.</p><p><strong>Results: </strong>We obtained five fractions named F<sub>1</sub>, F<sub>2</sub>, F<sub>3</sub>, F<sub>4</sub>, and F<sub>5</sub>. The F<sub>1</sub> and F<sub>2</sub> fractions showed procoagulant activity, and the F<sub>5</sub> fraction had anticoagulant activity. The molecular weight of F<sub>2.4.2</sub> from fraction F<sub>2</sub> and F<sub>5.1</sub> from fraction F<sub>5</sub> were analyzed by SDS-PAGE electrophoresis under the reducing condition. These factors were identified as a single protein band at the end of purification. The molecular weights of these purified fractions were estimated to be 7.5 kDa and 38 kDa for F<sub>5.1(b)</sub> and F<sub>2.4.2(b)</sub>, respectively.</p><p><strong>Conclusions: </strong>Our findings suggest an efficient and suitable procedure for the identification and purification of the procoagulant and anticoagulant factors of the venom of Iranian <i>E. carinatus</i> using the PT and APTT assays.</p>","PeriodicalId":14595,"journal":{"name":"Iranian Journal of Pharmaceutical Research","volume":"21 1","pages":"e127240"},"PeriodicalIF":1.8000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/e8/fa/ijpr-21-1-127240.PMC10024320.pdf","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Iranian Journal of Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5812/ijpr-127240","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 1

Abstract

Background: The venom of Echis carinatus contains both procoagulant and anticoagulant components that can either promote or block the blood coagulation cascade, and some of these components affect platelet function in different ways.

Objectives: The present study focuses on setting up a procedure for the purification of crude venom and designing appropriate clotting tests in order to characterize the procoagulant and anticoagulant fractions of E. carinatus venom.

Methods: Chromatographic methods, including gel filtration, ion-exchange chromatography, and reverse-phase high-performance liquid chromatography (HPLC), were applied for purifying these fractions. Coagulant activity testing, prothrombin time (PT), and activated partial thromboplastin time (APTT) were used to determine procoagulant and anticoagulant properties. For measuring molecular weight, 15% SDS-PAGE electrophoresis with a molecular weight standard ranging from 6.5 to 200 kDa was used.

Results: We obtained five fractions named F1, F2, F3, F4, and F5. The F1 and F2 fractions showed procoagulant activity, and the F5 fraction had anticoagulant activity. The molecular weight of F2.4.2 from fraction F2 and F5.1 from fraction F5 were analyzed by SDS-PAGE electrophoresis under the reducing condition. These factors were identified as a single protein band at the end of purification. The molecular weights of these purified fractions were estimated to be 7.5 kDa and 38 kDa for F5.1(b) and F2.4.2(b), respectively.

Conclusions: Our findings suggest an efficient and suitable procedure for the identification and purification of the procoagulant and anticoagulant factors of the venom of Iranian E. carinatus using the PT and APTT assays.

Abstract Image

Abstract Image

Abstract Image

伊朗特有棘鱼毒液抗凝和促凝组分的分离。
背景:棘鱼毒液中含有促凝剂和抗凝剂成分,可促进或阻断血凝级联反应,其中部分成分以不同方式影响血小板功能。目的:建立蛇毒粗毒液的纯化工艺,设计相应的凝血试验,对蛇毒的促凝和抗凝成分进行鉴定。方法:采用凝胶过滤、离子交换色谱、反相高效液相色谱等色谱方法进行纯化。凝血活性测试、凝血酶原时间(PT)和活化部分凝血活素时间(APTT)用于测定促凝和抗凝性能。分子量测定采用15% SDS-PAGE电泳,分子量标准为6.5 ~ 200 kDa。结果:得到F1、F2、F3、F4、F5五个馏分。F1和F2部分具有促凝活性,F5部分具有抗凝活性。在还原条件下,用SDS-PAGE电泳分析了F2.4.2和F5.1的分子量。在纯化结束时,这些因子被鉴定为单个蛋白带。F5.1(b)和F2.4.2(b)纯化后的分子量估计分别为7.5 kDa和38 kDa。结论:本研究结果提示了一种高效、合适的方法,可用于鉴定和纯化伊朗蛇毒的促凝血因子和抗凝血因子。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
3.40
自引率
6.20%
发文量
52
审稿时长
2 months
期刊介绍: The Iranian Journal of Pharmaceutical Research (IJPR) is a peer-reviewed multi-disciplinary pharmaceutical publication, scheduled to appear quarterly and serve as a means for scientific information exchange in the international pharmaceutical forum. Specific scientific topics of interest to the journal include, but are not limited to: pharmaceutics, industrial pharmacy, pharmacognosy, toxicology, medicinal chemistry, novel analytical methods for drug characterization, computational and modeling approaches to drug design, bio-medical experience, clinical investigation, rational drug prescribing, pharmacoeconomics, biotechnology, nanotechnology, biopharmaceutics and physical pharmacy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信